首页|复方苦参注射液治疗放射性肺损伤有效性的meta分析

复方苦参注射液治疗放射性肺损伤有效性的meta分析

扫码查看
目的 探讨复方苦参注射液(compound Kushen injection,CKI)治疗放射性肺损伤(radiation-induced lung injury,RILI)的有效性与安全性.方法 选取建库至2023年2月28日中国知网、万方数据库、维普数据库、中国生物医学文献服务系统、PubMed、Embase、The Cochrane Library等数据库公开发表的中英文CKI治疗RILI的RCT研究,应用RevMan5.4统计软件对提取数据进行meta分析.结果 检索文献64篇,最终共纳入文献12篇,包括1229例患者,其中CKI联合放疗组611例,单纯放疗组618例.Meta分析结果显示,CKI联合放疗组临床有效率和RILI 0~1级发生率高于单纯放疗组,放射性肺炎发生率、放射性肺纤维化发生率、RILI 2~5级发生率低于单纯放疗组;CKI联合放疗组CD3+、CD4+计数高于单纯放疗组,CD8+、TGF-β1及TNF-α水平低于单纯放疗组,差异均有统计学意义(P<0.05).结论 CKI联合放疗可以有效减少RILI发生率,改善患者免疫指标和血清TGF-β1、TNF-α的水平,值得临床推广.
Meta-analysis of the effectiveness of compound Kushen injection in the treatment of radiation-induced lung injury
Objective To explore the efficacy and safety of compound Kushen injection (CKI) in the treatment of radiation-induced lung injury (RILI). Methods The RCT research of CKI in the treatment of RILI in Chinese and English published by China knowledge network,Wanfang database,VIP database,China biomedical literature service system,PubMed、Embase、The Cochrane Library and other metabases up to February 28th,2023 was selected,and the extracted data were analyzed by using RevMan5.4 statistical software. Results A total of 64 articles were searched,and 12 literatures were finally included,including 1229 patients,of which there were 611 cases in CKI combined radiotherapy group and 618 cases in simple radiotherapy group. Meta-analysis results showed that the clinical effective rate and the incidence of RILI grade 0 to 1 in CKI combined radiotherapy group were higher than those in simple radiotherapy group,while the incidence of radiation pneumonia,radiation pulmonary fibrosis and RILI grade 2 to 5 were lower than those in the simple radiotherapy group. The counts of CD3+and CD4+in CKI combined radiotherapy group were higher than those in simple radiotherapy group,and the levels of CD8+,TGF-β1 and TNF-α in CKI combined radiotherapy group were lower than those in single radiotherapy group,the differences were statistically significant (P<0.05). Conclusions CKI combined with radiotherapy can effectively reduce the incidence of RILI,improve the status of immune sysmten and serum levels of TGF-β1 and TNF-α,which is worthy of clinical promotion.

compound Kushen injection (CKI)radiation-induced lung injury (RILI)efficacysafetymeta analysis

罗红梅、王颖杰、李京辰、海丽娜

展开 >

436099 鄂州市中医医院肿瘤科

空军特色医学中心放射治疗科

北京振东光明药物研究院有限公司学术部

北京振东光明药物研究院有限公司中药所

展开 >

复方苦参注射液 放射性肺损伤 有效性 安全性 系统评价

国家中药标准化项目山西省重点研发计划

ZYBZH-C-JIN-4320160303113011

2024

北京医学
中华医学会北京分会

北京医学

CSTPCD
影响因子:0.714
ISSN:0253-9713
年,卷(期):2024.46(5)